Dengue 3 Human Infection Model (DENV-3)

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions
Dengue
Interventions
BIOLOGICAL

Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)

Dengue subtype 3 Challenge Virus (DENV-3) strain CH53489 administered as a single injection.

Trial Locations (1)

13210

State University of New York, Upstate Medical University (SUNY-UMU), Syracuse

All Listed Sponsors
collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

U.S. Army Medical Research and Development Command

FED

lead

State University of New York - Upstate Medical University

OTHER

NCT04298138 - Dengue 3 Human Infection Model (DENV-3) | Biotech Hunter | Biotech Hunter